Carlo Colosimo

Recognizing iatrogenic movement disorders 1:58
Recognizing iatrogenic movement disorders
Carlo Colosimo • 16 Sep 2022
DBS & FUS: improvements for the treatment of Parkinson’s disease 1:13
DBS & FUS: improvements for the treatment of Parkinson’s disease
Carlo Colosimo • 27 Jun 2022
Updates on levodopa infusion therapies for advanced Parkinson’s disease 1:26
Updates on levodopa infusion therapies for advanced Parkinson’s disease
Carlo Colosimo • 27 Jun 2022
Genetic testing for dystonia 1:20
Genetic testing for dystonia
Carlo Colosimo • 27 Jun 2022
Advances in Parkinson’s disease biomarkers 1:49
Advances in Parkinson’s disease biomarkers
Carlo Colosimo • 27 Jun 2022
Highlights in Parkinson’s disease: subtyping & prodrome 1:40
Highlights in Parkinson’s disease: subtyping & prodrome
Carlo Colosimo • 27 Jun 2022
Long-term effect of botulinum toxin in cervical dystonia 3:24
Long-term effect of botulinum toxin in cervical dystonia
Carlo Colosimo • 7 Sep 2020
Atypical Parkinsonisms: clinical overview & challenges 3:28
Atypical Parkinsonisms: clinical overview & challenges
Carlo Colosimo • 7 Sep 2020
The content of VJNeurology is intended for healthcare professionals